| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $44.62B | -21.6% |
| Cost of Revenue | $39.74B | -17.8% |
| R&D Expense | $829.0M | -2.6% |
| SG&A Expense | $1.63B | -2.9% |
| Interest Expense | $746.0M | +12.7% |
| Pre-tax Income | $656.0M | -89.2% |
| Income Tax | -$4.0M | -100.3% |
| Net Income | $660.0M | -85.8% |
| EPS (Basic) | $0.82 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.99B | -23.1% |
| Accounts Receivable | $4.72B | -15.9% |
| Inventory | $6.08B | -13.1% |
| Current Assets | $17.61B | -14.0% |
| Total Assets | $57.97B | -4.3% |
| Current Liabilities | $9.96B | -12.1% |
| Long-term Debt | $14.91B | -1.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $5.20B | -30.5% |
| Investing Cash Flow | -$2.93B | +1.4% |
| Financing Cash Flow | -$3.12B | +7.3% |
| -87.0% |
| EPS (Diluted) | $0.82 | -86.9% |
| Stockholders' Equity |
| $18.61B |
| -10.2% |